HTI's model targets partnership opportunities and encourages strategic alliances between the public and private sectors; offering business planning, financing options, design, project construction and on-going management.
HTI is a unique and dynamic company established in response to the growing worldwide demand for a model of cancer care that is patient focused and delivered as close to the patient's own home as possible. Our highly focused mission is to develop comprehensive centers of excellence that will advance the diagnosis and treatment of cancer; either through public/private initiatives or through partnerships with quality local healthcare providers.
Thank you for your interest in HTI. Feel free to contact us with any questions.
Ron Gilden, President
Why Proton Therapy?
Proton therapy has clinically proven to provide positive results for cancer patients with certain site specific types of cancer. Our mission is to expand patient and consultant access to technologies and services which will improve clinical outcome for patients.
The directors of HTI have over 30 years of experience in healthcare delivery and have developed more than 200 diagnostic and treatment centres in the USA, Europe and Latin America. Click here to see a full list of our previous projects.
Cancer care specialists unveil plans for growth after Leeds deal
HTI are contracted to provide a turnkey design, build and equip satellite cancer centre to the main Guy's St.Thomas centre in London located in Sidcup on the Queen Mary campus. The agreement is funded directly through GSTT [ ... ]
New Compact Gantry for ProteusONE Proton Therapy System FDA Cleared
In a press release on July 16th of 2014, IBA announced that it has received Marketing Authorization from the U.S. Food and Drug A dministration (FDA) for its Compact Gantry Beam Line
IBA explains that, "Proteus® ONE [ ... ]